:-)
Tuesday July 9, 12:39 pm Eastern Time
Press Release
SOURCE: Discovery Partners International, Inc.
Discovery Partners International Announces the Appointment of Taylor J. Crouch To the Position of President and Chief Operating Officer
SAN DIEGO, July 9 /PRNewswire-FirstCall/ -- Discovery Partners International, Inc. (Nasdaq: DPII - News) today announced the appointment of Taylor J. Crouch to the position of President and Chief Operating Officer. Mr. Crouch brings to Discovery Partners over twenty years of experience in the pharmaceutical industry and will be instrumental in executing and expanding DPI's strategy as a technology driven drug discovery collaborations company.
Mr. Crouch, who, prior to joining DPI, was President and CEO of Variagenics, Inc. (Nasdaq: VGNX - News), a biotechnology company specializing in pharmacogenomics, will be responsible for the management of all of DPI's operating activities.
"We are pleased to have an executive of Taylor's caliber join DPI," said Riccardo Pigliucci, Chairman and Chief Executive Officer of Discovery Partners. "His addition marks the latest step toward our goal of strengthening our management team and positioning the company for future growth."
"Taylor's appointment will ensure undivided attention to our partners and to our day to day operations while allowing me to devote more energy to evaluate and pursue strategic opportunities to further accelerate the company's growth and to expand its technology base," concluded Pigliucci.
"I'm delighted to join DPI and to help drive its leadership position in the critical area of drug discovery for the biopharmaceutical industry," Crouch said. "There is a bottleneck forming in this significant value creation area of the drug R&D process, and DPI is extremely well-positioned -- with its leading technologies, its outstanding global team, and its validating partnerships -- to play an important role in the development of promising new drug candidates."
In his prior role at Variagenics from 1999 to 2002, Crouch led the transition of the company from private to public, establishing key R&D deals with the pharmaceutical, biopharmaceutical, and life sciences industries. From 1991 to 1999 he was Senior Vice President, Worldwide Marketing and Strategic Development for PAREXEL International Corp., leading PAREXEL's global sales, marketing and strategy functions, where he worked with client companies to establish broad based strategic partnering relationships in all major pharmaceutical marketplaces. Prior to joining PAREXEL, Mr. Crouch spent ten years in the pharmaceutical industry at Schering-Plough International, and Pfizer. |
